New Molecular Techniques to Study the Skin Microbiota of Diabetic Foot Ulcers
- PMID: 25566413
- PMCID: PMC4281861
- DOI: 10.1089/wound.2014.0532
New Molecular Techniques to Study the Skin Microbiota of Diabetic Foot Ulcers
Abstract
Significance: Diabetic foot ulcers (DFU) are a major and growing public health problem. They pose difficulties in clinical practice in both diagnosis and management. Bacterial interactions on the skin surface are important in the pathophysiology of DFU and may contribute to a delay in healing. Fully identifying bacteria present in these wounds is difficult with traditional culture methods. New molecular tools, however, have greatly contributed to our understanding of the role of the cutaneous microbiota in DFU. Recent Advances: Molecular technologies revealed new information concerning how bacteria are organized in DFU. This has led to the concept of "functionally equivalent pathogroups," meaning that certain bacterial species which are usually nonpathogenic (or at least incapable of maintaining a chronic infection on their own) may coaggregate symbiotically in a pathogenic biofilm and act synergistically to cause a chronic infection. The distribution of pathogens in multispecies biofilms is nonrandom. The high bacterial diversity is probably related to the development of a microbial biofilm that is irreversibly attached to the wound matrix. Critical Issues: Using molecular techniques requires a financial outlay for high-cost equipment. They are still too time-consuming to perform and reporting is too delayed for them to be used in routine practice. Finally, they do not differentiate live from dead or pathogenic from nonpathogenic microorganisms. Future Directions: Molecular tools have better documented the composition and organization of the skin flora. Further advances are required to elucidate which among the many bacteria in the DFU flora are likely to be pathogens, rather than colonizers.
Figures
References
-
- Singh N, Armstrong DG, Lispky BA. Preventing foot ulcers in patients with diabetes. JAMA 2005;293:217–228 - PubMed
-
- Prompers L, Huijberts M, Schaper N, et al. Resource utilisation and costs associated with the treatment of diabetic foot ulcers. Prospective data from the Eurodiale study. Diabetologia 2008;51:1826–1834 - PubMed
-
- Lipsky BA, Berendt AR, Deery HG, et al. Infectious Diseases Society of America. Diagnosis and treatment of diabetic foot infection. Clin Infect Dis 2004;39:885–910 - PubMed
-
- Lavery LA, Armstrong DG, Wunderlich RP, Boulton AJM, Tredwell JM. Diabetic foot syndrome: evaluating the prevalence and incidence of foot pathology in Mexican Americans and non-Hispanic whites from a diabetes disease management cohort. Diabetes Care 2003;26:1435–1438 - PubMed
-
- Jeffcoate WJ, Lipsky BA, Berendt AR, et al. International Working Group on the Diabetic Foot. Unresolved issues in the management of ulcers of the foot in diabetes. Diabet Med 2008;25:1380–1389 - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
